Jeff Schaffnit discusses Sanofi's advancements in BTK inhibitors and promising results for hemophilia A therapies at ASH 2025 ...

Novartis is divulging details from ianalumab’s summertime | Novartis is divulging details from ianalumab’s phase 3 win in a rare autoimmune blood disorder, and the data suggest the treatment could del ...

This might sound surprising, but getting diagnosed with immune thrombocytopenia (also known as idiopathic thrombocytopenic purpura, or ITP) can come as a relief. You can figure out ITP treatment, of ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal ...

EAST HANOVER, N.J., Oct. 18, 2017 /PRNewswire/ -- Novartis today announced long-term study results supporting the positive safety and efficacy of Promacta (eltrombopag) in adults with ...

The FDA has approved Doptelet (avatrombopag; Dova) for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous ...

Elana, 36, was a teenager when she was diagnosed with immune thrombocytopenia, also known as idiopathic thrombocytopenic purpura or ITP. ITP is a blood disorder in which you have fewer than average ...

Formerly known as idiopathic thrombocytopenic purpura, immune thrombocytopenia (ITP) is an acquired autoimmune condition characterized by increased platelet destruction and impaired platelet ...

—A small study of patients taking thrombopoietin receptor agonists detected correlations between absolute immature platelet fraction levels and bone marrow morphology. Reviewed by Julia M. Cunningham, ...

The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called ...

Chronic ITP is a serious autoimmune disorder characterized by low platelet counts in the blood (thrombocytopenia), which can lead to serious bleeding events. Recognized as an orphan disease, chronic ...

What Is Doptelet, and Why Does It Matter? Doptelet (avatrombopag) is a prescription medicine that helps the body make more platelets (cells that help stop bleeding). First approved in 2018 for adults, ...